Effect of Unmetabolized Folic Acid on Immunoinflammatory Markers in Sickle Cell Disease Patients Taking Folic Acid Supplementation

Overview

Journal Indian J Clin Biochem

Specialty Biochemistry

Date 2024 Sep 30

PMID 39346717

Authors

Diksha Chandrakar

Suprava Patel

Preetam N Wasnik

Eli Mohapatra

Rachita Nanda

Seema Shah

Dablu L Gupta

Affiliations

Soon will be listed here.

Abstract

Folic acid (FA) supplementation in sickle cell disease (SCD) patients lead to accumulation of unmetabolized folic acid (UMFA) which might influence the level of cytokines and NK cell activity and thus trigger the crisis event. The aim of the study was to investigate the effect of UMFA levels on immuno-inflammatory markers in SCD patients taking FA supplementation. The cross-sectional study was conducted on 60 HbSS confirmed SCD cases with 22 crisis and 38 cases at steady state of 15-40 years age group. Serum FA, 5-Methyl Tetrahydrofolate (5-MTHF), Dihydrofolate reductase, Interleukin-6 (IL-6), Highly sensitive C-Reactive Protein (HsCRP), and natural killer (NK) cell activity were estimated. More than 50% of the study population depicted presence of UMFA. The median UMFA level was significantly elevated in crisis group (131.8 ng/mL) as compared to the steady state group (36.31 ng/mL) ( = 0.041). The median value of HsCRP was significantly higher in the crisis group (18.41 mg/L) than the steady state group (2.04 mg/L) ( = 0.003). Similarly, IL-6 was higher in crisis group (13.29 pg/mL) than steady state group (5 pg/mL) ( = 0.060). The median NK cell activity was 39.28 nmol/L in crisis group and 35.31 nmol/L in steady state groups ( = 0.889). In bivariate correlation analysis, UMFA showed a significant negative correlation with NK cell activity (r = - 0.638; = < 0.001) and a positive correlation with IL-6 (r = 0.571; = 0.001) and HsCRP (r = 0.237; = 0.200). Accumulation of UMFA affect NK cell activity, thus influence the vulnerability for crisis state. Therefore, dosage modification for FA supplementation in SCD patients is suggested.

References

Akohoue S, Shankar S, Milne G, Morrow J, Chen K, Ajayi W . Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007; 61(2):233-8. DOI: 10.1203/pdr.0b013e31802d7754. View

Keikhaei B, Mohseni A, Norouzirad R, Alinejadi M, Ghanbari S, Shiravi F . Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. Eur Cytokine Netw. 2013; 24(1):45-52. DOI: 10.1684/ecn.2013.0328. View

Allali S, Trovati Maciel T, Hermine O, De Montalembert M . Innate immune cells, major protagonists of sickle cell disease pathophysiology. Haematologica. 2020; 105(2):273-283. PMC: 7012475. DOI: 10.3324/haematol.2019.229989. View

Mohammed F, Mahdi N, Sater M, Al-Ola K, Almawi W . The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease. Blood Cells Mol Dis. 2010; 45(4):293-6. DOI: 10.1016/j.bcmd.2010.08.003. View

Panigrahi S, Patra P, Khodiar P . The screening and morbidity pattern of sickle cell anemia in chhattisgarh. Indian J Hematol Blood Transfus. 2014; 31(1):104-9. PMC: 4275531. DOI: 10.1007/s12288-014-0407-z. View

Paniz C, Bertinato J, Lucena M, De Carli E, Amorim P, Gomes G . A Daily Dose of 5 mg Folic Acid for 90 Days Is Associated with Increased Serum Unmetabolized Folic Acid and Reduced Natural Killer Cell Cytotoxicity in Healthy Brazilian Adults. J Nutr. 2017; 147(9):1677-1685. PMC: 5712455. DOI: 10.3945/jn.117.247445. View

Udezue E, Girshab A . Differences between males and females in adult sickle cell pain crisis in eastern Saudi Arabia. Ann Saudi Med. 2004; 24(3):179-82. PMC: 6147926. DOI: 10.5144/0256-4947.2004.179. View

Bayer A, Fraker C . The Folate Cycle As a Cause of Natural Killer Cell Dysfunction and Viral Etiology in Type 1 Diabetes. Front Endocrinol (Lausanne). 2017; 8:315. PMC: 5703744. DOI: 10.3389/fendo.2017.00315. View

Kazazian Jr H, Orkin S, Boehm C, Sexton J, Antonarakis S . beta-Thalassemia due to a deletion of the nucleotide which is substituted in the beta S-globin gene. Am J Hum Genet. 1983; 35(5):1028-33. PMC: 1685822. View

10.

Hockham C, Bhatt S, Colah R, Mukherjee M, Penman B, Gupta S . The spatial epidemiology of sickle-cell anaemia in India. Sci Rep. 2018; 8(1):17685. PMC: 6283872. DOI: 10.1038/s41598-018-36077-w. View

11.

Tang J, Cait A, White R, Arabshahi H, OSullivan D, Gasser O . MR1-dependence of unmetabolized folic acid side-effects. Front Immunol. 2022; 13:946713. PMC: 9395688. DOI: 10.3389/fimmu.2022.946713. View

12.

Okocha C, Manafa P, Ozomba J, Ulasi T, Chukwuma G, Aneke J . C-reactive Protein and Disease Outcome in Nigerian Sickle Cell Disease Patients. Ann Med Health Sci Res. 2014; 4(5):701-5. PMC: 4199159. DOI: 10.4103/2141-9248.141523. View

13.

Tam C, OConnor D, Koren G . Circulating unmetabolized folic Acid: relationship to folate status and effect of supplementation. Obstet Gynecol Int. 2012; 2012:485179. PMC: 3317000. DOI: 10.1155/2012/485179. View

14.

Ndefo U, Maxwell A, Nguyen H, Chiobi T . Pharmacological management of sickle cell disease. P T. 2009; 33(4):238-43. PMC: 2730092. View

15.

Williams B, Mayer C, McCartney H, Devlin A, Lamers Y, Vercauteren S . Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease. Front Nutr. 2021; 8:642306. PMC: 8096995. DOI: 10.3389/fnut.2021.642306. View

16.

Ceglie G, Di Mauro M, Tarissi de Jacobis I, de Gennaro F, Quaranta M, Baronci C . Gender-Related Differences in Sickle Cell Disease in a Pediatric Cohort: A Single-Center Retrospective Study. Front Mol Biosci. 2019; 6:140. PMC: 6906547. DOI: 10.3389/fmolb.2019.00140. View

17.

Troen A, Mitchell B, Sorensen B, Wener M, Johnston A, Wood B . Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2005; 136(1):189-94. DOI: 10.1093/jn/136.1.189. View

18.

Asbaghi O, Ashtary-Larky D, Bagheri R, Moosavian S, Nazarian B, Afrisham R . Effects of Folic Acid Supplementation on Inflammatory Markers: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021; 13(7). PMC: 8308638. DOI: 10.3390/nu13072327. View

19.

Silva-Junior A, Garcia N, Cardoso E, Dias S, Tarrago A, Fraiji N . Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients. Front Immunol. 2021; 12:559925. PMC: 7990896. DOI: 10.3389/fimmu.2021.559925. View

20.

Nader E, Romana M, Connes P . The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease. Front Immunol. 2020; 11:454. PMC: 7082402. DOI: 10.3389/fimmu.2020.00454. View